Our Medical Experts

Behind Options MD is a team of experienced medical experts. They worked together with the founders, Morgan and Kyle, to create a unique virtual healthcare practice focused on providing treatment to individuals with major depressive disorder who have treatment-resistant depression

The medical experts behind Options MD bring together a wealth of experience and knowledge in the healthcare industry. Each of their unique experiences helped to shape the individual care treatment and approach that makes Options MD different.

Dr. Carl Marci

Dr. Marci is a physician, scientist, author, and entrepreneur in the health and technology sectors. He is a board-certified psychiatrist at Massachusetts General Hospital and a part-time Assistant Professor of Psychiatry at Harvard Medical School.

Dr. Marci is a strategic advisor and Interim Chief Medical Officer to Options MD. He has worked hand-in-hand with Options MD’s founders on go-to-market and clinical operations strategies.

He has been integral in developing Options MD’s patient assessment and treatment-matching logic, as well as helping management recruiting and onboard clinical hires.

Previously, Dr. Marci was Chief Psychiatrist or Chief Medical Officer at a number of venture-backed technology-enabled companies. He was the  co-founder, Chairman, and Chief Executive Officer of Innerscope Research, a pioneer in the field of consumer neuroscience. Innerscope Research was a data science and media research firm acquired by Nielsen in 2015, where he served as the first Global Chief Neuroscientist until 2019.

Dr. Marci received his B.A. with honors from Columbia University, M.A. from Oxford University as a Rhodes Scholar, and M.D. with honors from Harvard Medical School.

He completed two NIH fellowships in neuroscience, published numerous articles in peer-reviewed science journals, holds seven patents, and gives lectures nationally and internationally.

He is also the author of a new book on the impact of mobile media, communications, and information technology on the developing brain, published by Harvard University Press. The book is titled “Rewired: Protecting Your Brain in the Digital Age.”

Dr. Marci is also a member of the Aspen Global Leadership Network as a 2014 Henry Crown Fellow.

Dr. Hants Williams

Dr. Hants Williams is a ‘full-stack’ healthcare professional who provides the functional skills of a care provider, data engineer, and clinical operations specialist to help Options MD thrive. 

Dr. Williams is passionate about behavioral health and chronic disease management. He has published and created non-pharmacological behavioral approaches for managing complex patients with some of the most difficult conditions, such as chronic pain, substance use disorder, and affective disorders. 

His work has been previously published in peer-reviewed journals that include “Journal of Pain and Symptom Management” and “BMC-Trials.”

He has also led clinical informatics at a large EMR vendor serving 10+ million people (VirtualHealth), designed initial patient screening tools and developed initial outcome measurements (Parsley Health), and helped aggregate and make more accessible public datasets related to SDoH (National Health IT Collaborative for the Underserved), and continuously helps companies achieve their funding goals via governmental grants, venture capital, and private equity groups.

Dr. Andrew Leuchter

Andrew Leuchter, MD, is an expert on the treatment of mood disorders and is a Medical Advisor to Options MD. He is a Distinguished Professor of Psychiatry and Behavioral Sciences at UCLA, where he also directs the Neuromodulation Division as well as the Transcranial Magnetic Stimulation (TMS) Clinical and Research Service. The TMS Clinical and Research Service perform more than 7,000 individual TMS treatments each year for patients with treatment-resistant depression, chronic pain, obsessive-compulsive disorder, and other neuropsychiatric illnesses. 

He also maintains an active clinical practice, specializing in consultation and care for patients suffering from treatment-resistant depression.

Dr. Leuchter leads clinical trials to develop novel neuromodulation methods for the treatment of depression, pain, and Post-Traumatic Stress Disorder (PTSD), studying technologies such as TMS and Trigeminal Nerve Stimulation (TNS). He uses brain-imaging techniques, such as quantitative electroencephalography (qEEG), magnetic resonance imaging (MRI), and positron emission tomography (PET), to examine brain function and predict which treatments are most likely to benefit individual patients.

Dr. Leuchter’s research programs combine clinical trials with neurophysiology and brain-imaging studies to inform clinical practice in treating depression.

He has authored over 200 scientific articles on topics including theories of antidepressant action, neuromodulation for the treatment of depression, and EEG biomarkers to guide the treatment of neuropsychiatric illness. 

Dr.Leuchter is a member of several professional organizations, including the American Psychiatric Association and the Clinical TMS Society.

He is a graduate of Stanford University earned his medical degree at the Baylor College of Medicine in Houston, Texas.

Dr. Michelle Drapkin

Dr. Drapkin is the Founder and Director of the Cognitive Behavior Therapy (CBT) Center. She is a Board-Certified Clinical Psychologist and is licensed in all of New Jersey, New York,  and Pennsylvania and approved by PSYPACT to treat patients via telehealth in 30+ states. She is an advisor to Options MD. 

She previously held roles as a Senior Behavioral Scientist at Johnson and Johnson where she led the development and deployment of behavior change interventions, including interventions for well-being, mindfulness, and burnout prevention. She led a national position at the Department of Veterans Affairs and was on faculty at the University of Pennsylvania and Rutgers, The State University of New Jersey. 

Dr. Drapkin has dedicated her professional career to using psychological research to help people. She completed her PhD in Clinical Psychology from Rutgers, The State University of New Jersey and her postdoctoral fellowship in addictions treatment research at the University of California, San Diego.

She is also the sole author of an upcoming book on behavior change from New Harbinger Publications.

She is trained in, practices and trains other healthcare providers in a variety of evidence-based practices, including 

  • Cognitive Behavioral Therapy (CBT)
  • Motivational Interviewing (MI)
  • Dialectical Behavior Therapy (DBT)
  • Prolonged Exposure (PE) for PTSD
  • Acceptance and Commitment Therapy (ACT)

Dr. Drapkin uses her over 20 years of experience to advise Options MD clinicians on how best to develop effective, evidence-based treatment plans to suit unique individual needs.

Dr. Joshua Cohen

Dr. Cohen is the Chief Resident for Research at the University of California San Francisco. His clinical and research work focuses on mood disorders, particularly treatment-resistant depression. 

At the San Francisco VA, Dr. Cohen works in the specialty Mood Disorder Clinic, where he helps veterans using a wide variety of psychopharmacological, behavioral, and interventional approaches, including the most cutting-edge treatments for depression, such as Transcranial Magnetic Stimulation and Ketamine

Dr. Cohen’s research aims to develop novel deep-brain stimulation therapies for depression and anxiety. His current work investigates the effect of synchrony between brain regions and circuits on emotional state.

At Options MD, Dr. Cohen is developing proprietary patient assessments to more accurately diagnose patients, predict side effects, identify personalized treatment plans for patients, and track symptoms and recovery over time. Dr. Cohen works with the Options MD data science team to integrate gold-standard assessment metrics into our ever-evolving treatment-matching algorithm.

Dr. Natalie Sheils

Dr. Natalie Sheils is currently a director of AI and data science research at Sequelae. She worked previously at Optum, part of UnitedHealth Group as director of healthcare economics and a research scientist focused on AI and computational tools for healthcare. 

Before joining UnitedHealth Group, Dr. Sheils earned her Ph.D. in applied mathematics from the University of Washington. She did a postdoctoral fellowship at the University of Minnesota School of Mathematics. 

Dr. Sheils is an author of more than 25 peer-reviewed journal articles and a frequent speaker at conferences, seminars, and colloquia. She serves as an advisor to Options MD. In this role, she advises on research projects, randomized control trial completion, prioritization of technical projects, and the build-out of algorithms in preparation for AI Learning.

Options MD

Mon-Fri 9am - 9pm Central

Sat & Sun Noon - 5 Central

If you or someone you know are actively experiencing suicidal thoughts, are in crisis or in an emergency, call 988. If you are struggling and need someone to talk to right now, the resources below provide free and confidential assistance 24/7:

The 988 Suicide and Crisis Lifeline: 988 | Crisis Text Line: Text HOME to 741741

Suicide Prevention Lifeline: (800) 273-8255
2022 All Rights Reserved
Call
Email
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram